GTX-0196

N/A

Report date: 2026/01/22 16:42:31
NME

Base Information

Drug NameGTX-0196
Drug Alias NameGTX-0196
ClassificationSmall molecules
Mechanisms of ActionDihydroorotate dehydrogenase inhibitors
TargetsDihydroorotate dehydrogenase
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenase Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesGenase Therapeutics BV
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A